Literature DB >> 8315179

Alterations in glucose metabolism in patients with Alzheimer's disease.

G S Meneilly1, A Hill.   

Abstract

OBJECTIVE: To determine the alterations in glucose metabolism that occur in patients with Alzheimer's Disease (AD).
DESIGN: Cross-sectional comparison of AD and healthy controls.
SETTING: A University teaching hospital. PATIENTS: Healthy controls (n = 14, BMI: 24.9 +/- 0.5 kg/M2, age 73 +/- 1 years) and patients with AD (n = 12, BMI: 23.9 +/- 1.0 kg/M2, age 72 +/- 1 years). All controls and patients with AD had a normal history and physical examination, a negative family history of diabetes, and took no medications. MEASUREMENTS: All patients and controls underwent an assessment of their dietary intake and physical activity, a 3-hour oral glucose tolerance test (OGTT), and a 2-hour hyperglycemic glucose clamp study.
RESULTS: Total caloric intake (AD: 27.1 +/- 1.3 kcal/kg/day; CONTROL: 23.6 +/- 1.6 kcal/kg/day; P = ns) and intake of complex carbohydrates (AD: 5.9 +/- 0.4 kcal/kg/day; CONTROL: 6.5 +/- 0.3 kcal/kg/day; P = ns) were not different between groups. Leisure time physical activity was greater in controls (AD: 2970 +/- 411 kcal/week; CONTROL: 5229 +/- 864 kcal/week; P < 0.05). Patients with AD had higher fasting glucose (AD: 5.9 +/- 0.2 mmol/L; CONTROL: 5.1 +/- 0.1 mmol/L; P < 0.01) and insulin (AD: 144 +/- 20 pmol/L; CONTROL: 100 +/- 6 pmol/L; P < 0.05) values. In response to the OGTT, the area under the curve for glucose and insulin was similar in both groups. During the hyperglycemic clamp, steady-state glucose values were higher in the Alzheimer's patients (AD: 11.5 +/- 0.2 mmol/L; CONTROL: 10.9 +/- 0.1 mmol/L, P < 0.01). First- and second-phase insulin responses were similar in each group. The insulin sensitivity index (units: mL/kg.min per pmol/L x 100), a measure of tissue sensitivity to insulin, was reduced in the patients with AD (AD: 0.59 +/- 0.06; CONTROL: 0.79 +/- 0.07; P < 0.05).
CONCLUSIONS: We conclude that early AD is characterized by alterations in peripheral glucose metabolism, which may relate, in part, to alterations in physical activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315179     DOI: 10.1111/j.1532-5415.1993.tb07458.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  14 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

3.  Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.

Authors:  S Sauder; H Kölsch; D Lütjohann; A Schulz; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

Review 4.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

Review 5.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

Review 6.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Insulin receptors in mouse brain: Reversibility of age-related impairments by a thymic extract.

Authors:  A Zaia; L Piantanelli
Journal:  J Am Aging Assoc       Date:  2000-07

Review 8.  The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.

Authors:  Kaushik Shah; Shanal Desilva; Thomas Abbruscato
Journal:  Int J Mol Sci       Date:  2012-10-03       Impact factor: 5.923

9.  Plasma aβ: a possible missing link between Alzheimer disease and diabetes.

Authors:  Naoyuki Sato; Ryuichi Morishita
Journal:  Diabetes       Date:  2013-04       Impact factor: 9.461

Review 10.  Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.

Authors:  Nathaniel G N Milton
Journal:  Drugs Aging       Date:  2004       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.